超越生存:儿童创伤不良结局的早期标志物
该回顾性分析纳入2024年8月至2025年7月入住三级儿科重症监护室的88例儿童创伤患者,排除入院24小时内死亡者。入院当天计算PRISM III、PELOD-2、SIPA、GCS和VIS评分,并记录乳酸、降钙素原和白蛋白等实验室指标,以出院时持续器官特异性功能障碍定义并发症。总死亡率为5.7%,13.6%患者出现后遗症;死亡者PRISM III、PELOD-2、乳酸、乳酸/白蛋白比值和降钙素原均显著更高,乳酸/白蛋白比值对死亡预测AUC=0.828,对并发症负预测值95.6%。作者认为将联合评分与生物标志物策略纳入儿童创伤早期风险分层方案有支持依据。
要点
- 儿童创伤患者入院时乳酸/白蛋白比值对死亡预测AUC=0.828,为所评估指标中最高。
- 乳酸/白蛋白比值对并发症的负预测值达95.6%,可用于排除不良结局风险。
- 死亡者PRISM III、PELOD-2、乳酸、乳酸/白蛋白比值和降钙素原均显著高于存活者,且PICU停留更长、机械通气和正性肌力支持需求更大。
- 出现后遗症者病情严重度评分和乳酸相关标志物显著更高,输血需求也更常见。
- 作者认为将联合评分与生物标志物策略纳入儿童创伤早期风险分层方案有支持依据。
适用人群与场景
- 2024年8月至2025年7月入住三级儿科重症监护室的儿童创伤患者,共88例。
- 排除入院24小时内死亡的患者。
诊断标准与关键阈值
- 并发症定义为出院时持续器官特异性功能障碍。
- 入院当天计算PRISM III、PELOD-2、SIPA、GCS和VIS评分。
研究设计与关键结果
- 研究类型为回顾性分析,纳入88例儿童创伤患者,总死亡率为5.7%,13.6%患者出现后遗症。
- 死亡者PRISM III、PELOD-2、乳酸、乳酸/白蛋白比值和降钙素原水平显著更高,PICU停留更长,机械通气和正性肌力支持需求更大。
- 乳酸/白蛋白比值对死亡预测AUC=0.828,为所评估指标中最高。
- 出现后遗症者病情严重度评分和乳酸相关标志物显著更高,输血需求也更常见。
- 乳酸/白蛋白比值对并发症的负预测值=95.6%。
证据类型、等级与局限
- 证据类型为回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现支持将联合评分与生物标志物策略纳入儿童创伤早期风险分层方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to evaluate the prognostic value of clinical scoring systems and admission-based laboratory biomarkers in predicting mortality and morbidity among pediatric trauma patients.
METHODS: We conducted a retrospective analysis of 88 pediatric trauma patients admitted to a tertiary-level pediatric intensive care unit between August 2024 and July 2025. Patients who died within the first 24 h were excluded. PRISM III, PELOD-2, SIPA, GCS, and VIS scores were calculated on the day of admission. Laboratory parameters including lactate, procalcitonin, and albumin levels were recorded. Morbidity was defined as persistent organ-specific dysfunction at discharge. Receiver operating characteristic (ROC) analysis was used to evaluate predictive performance.
RESULTS: The overall mortality rate was 5.7 %, while 13.6 % of patients developed sequelae. Non-survivors had significantly higher PRISM III, PELOD-2, lactate, lactate/albumin ratio, and procalcitonin levels, along with longer PICU stay and greater need for mechanical ventilation and inotropic support. The lactate/albumin ratio showed the highest predictive value for mortality (AUC = 0.828). Patients with sequelae had significantly higher illness severity scores and elevated lactate-related markers. Transfusion needs were also more common in this group. Lactate/albumin ratio demonstrated strong negative predictive value (NPV = 95.6 %) for morbidity.
CONCLUSION: Both clinical severity scores and lactate-related biomarkers were associated with mortality and morbidity in pediatric trauma patients. In particular, the lactate/albumin ratio emerged as a useful early indicator of poor outcomes. These findings support the incorporation of combined scoring and biomarker strategies into early risk stratification protocols in pediatric trauma care.
参考来源
- Guvenc KB, Sahin EG, Yılmaz IA, et al. Beyond survival: Early markers of poor outcome in pediatric trauma. Am J Emerg Med. 2025. PMID: 41494231. doi:10.1016/j.ajem.2025.12.028
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。